Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A

Figure 4

GO enrichment analysis for the targets in biochanin A treating osteosarcoma (p value<0.01 and FDR<0.01). The y-axis shows significantly enriched GO categories of the target genes, and the x-axis shows the enrichment scores of these terms or the counts of targets.